• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型工程化的HIV-1东非分支A gp160质粒构建体在体内诱导强烈的体液免疫和细胞介导的免疫反应。

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

作者信息

Muthumani Karuppiah, Zhang Donghui, Dayes Nathanael S, Hwang Daniel S, Calarota Sandra A, Choo Andrew Y, Boyer Jean D, Weiner David B

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Virology. 2003 Sep 15;314(1):134-46. doi: 10.1016/s0042-6822(03)00459-8.

DOI:10.1016/s0042-6822(03)00459-8
PMID:14517067
Abstract

HIV-1 sequences are highly diverse due to the inaccuracy of the viral reverse transcriptase. This diversity has been studied and used to categorize HIV isolates into subtypes or clades, which are geographically distinct. To develop effective vaccines against HIV-1, immunogens representing different subtypes may be important for induction of cross-protective immunity, but little data exist describing and comparing the immunogenicity induced by different subtype-based vaccines. This issue is further complicated by poor expression of HIV structural antigens due to rev dependence. One costly approach is to codon optimize each subtype construct to be examined. Interestingly, cis-acting transcriptional elements (CTE) can also by pass rev restriction by a rev independent export pathway. We reasoned that rev+CTE constructs might have advantages for such expression studies. A subtype A envelope sequence from a viral isolate from east Africa was cloned into a eukaryotic expression vector under the control of the CMV-IE promoter. The utility of inclusion of the Mason-Pfizer monkey virus (MPV)-CTE with/without rev for driving envelope expression and immunogenicity was examined. Expression of envelope (gp120) was confirmed by immunoblot analysis and by pseudotype virus infectivity assays. The presence of rev and the CTE together increased envelope expression and viral infection. Furthermore the CTE+rev construct was significantly more immunogenic then CTE alone vector. Isotype analysis and cytokine profiles showed strong Th1 response in plasmid-immunized mice, which also demonstrated the superior nature of the rev+CTE construct. These responses were of similar or greater magnitude to a codon-optimized construct. The resulting cellular immune responses were highly cross-reactive with a HIV-1 envelope subtype B antigen. This study suggests a simple strategy for improving the expression and immunogenicity of HIV subtype-specific envelope antigens as plasmid or vector-borne immunogens.

摘要

由于病毒逆转录酶的不准确性,HIV-1序列具有高度多样性。这种多样性已被研究并用于将HIV分离株分类为亚型或进化枝,它们在地理上是不同的。为了开发针对HIV-1的有效疫苗,代表不同亚型的免疫原对于诱导交叉保护性免疫可能很重要,但描述和比较不同基于亚型的疫苗所诱导的免疫原性的数据很少。由于对rev的依赖性,HIV结构抗原的表达不佳使这个问题更加复杂。一种成本高昂的方法是对每个要检测的亚型构建体进行密码子优化。有趣的是,顺式作用转录元件(CTE)也可以通过独立于rev的输出途径绕过rev限制。我们推断,rev+CTE构建体在这种表达研究中可能具有优势。将来自东非病毒分离株的A亚型包膜序列克隆到受CMV-IE启动子控制的真核表达载体中。研究了包含/不包含rev的猴空泡病毒(MPV)-CTE对驱动包膜表达和免疫原性的效用。通过免疫印迹分析和假型病毒感染性测定证实了包膜(gp120)的表达。rev和CTE共同存在增加了包膜表达和病毒感染。此外,CTE+rev构建体的免疫原性明显强于单独的CTE载体。同型分析和细胞因子谱显示,在质粒免疫的小鼠中存在强烈的Th1反应,这也证明了rev+CTE构建体的优越性。这些反应与密码子优化构建体的反应相似或更强。产生的细胞免疫反应与HIV-1包膜B亚型抗原具有高度交叉反应性。这项研究提出了一种简单的策略,可提高HIV亚型特异性包膜抗原作为质粒或载体携带的免疫原的表达和免疫原性。

相似文献

1
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.新型工程化的HIV-1东非分支A gp160质粒构建体在体内诱导强烈的体液免疫和细胞介导的免疫反应。
Virology. 2003 Sep 15;314(1):134-46. doi: 10.1016/s0042-6822(03)00459-8.
2
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.由表达来自A、B、C和FGH亚型多个基因和表位共有序列的人类免疫缺陷病毒1型DNA免疫原诱导的跨亚型保护作用。
Viral Immunol. 2005;18(4):678-88. doi: 10.1089/vim.2005.18.678.
3
Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.基于一株主要的、CCR5嗜性的早期1型人类免疫缺陷病毒分离株(BX08)并采用人类密码子的合成包膜DNA疫苗的构建、生物活性及免疫原性。
AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1997-2008. doi: 10.1089/088922200750054738.
4
Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.将HIV DNA疫苗与细胞因子表达质粒进行局部应用可诱导强烈的抗原特异性免疫反应。
Vaccine. 2001 Oct 12;20(1-2):42-8. doi: 10.1016/s0264-410x(01)00324-3.
5
Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.使用哺乳动物密码子的不依赖Rev的合成HIV-1 gp160包膜基因进行基因枪DNA疫苗接种。
Vaccine. 1999 Apr 23;17(17):2166-75. doi: 10.1016/s0264-410x(98)00474-5.
6
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses.修饰HIV-1包膜糖蛋白gp160基因以增强质粒DNA疫苗引发的细胞介导免疫反应。
Vaccine. 2008 Sep 19;26(40):5083-94. doi: 10.1016/j.vaccine.2008.03.092. Epub 2008 Apr 24.
7
A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.单次给予表达全长人类免疫缺陷病毒1型(HIV-1)(HXB2)Rev/Env或密码子优化的HIV-1(JR-FL)gp120的慢病毒载体可在小鼠体内产生持久的免疫反应。
J Gen Virol. 2006 Jun;87(Pt 6):1625-1634. doi: 10.1099/vir.0.81706-0.
8
Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.巨噬细胞炎性蛋白-1α(MIP-1α)表达质粒增强DNA疫苗诱导的针对HIV-1的免疫反应。
Clin Exp Immunol. 1999 Feb;115(2):335-41. doi: 10.1046/j.1365-2249.1999.00793.x.
9
Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.HIV多核苷酸疫苗接种后的细胞毒性T淋巴细胞和辅助性T细胞反应。
Ann N Y Acad Sci. 1995 Nov 27;772:198-208. doi: 10.1111/j.1749-6632.1995.tb44745.x.
10
Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice.用HIV-1 B亚型gp160-DNA进行免疫接种可在小鼠体内诱导特异性以及交叉反应性免疫应答。
Indian J Med Res. 2001 Jul;114:1-9.

引用本文的文献

1
A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus.一种新型合成 DNA 疫苗可引发针对波瓦桑病毒的保护性免疫应答。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008788. doi: 10.1371/journal.pntd.0008788. eCollection 2020 Oct.
2
Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines.腺苷脱氨酶-1 增强了 HIV-1 包膜 DNA 和蛋白疫苗的生发中心形成和功能性抗体反应。
Vaccine. 2020 May 8;38(22):3821-3831. doi: 10.1016/j.vaccine.2020.03.047. Epub 2020 Apr 10.
3
Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.
共施用表达核因子κB亚基p65/RelA或1型转录激活因子T-bet的分子佐剂可增强抗原特异性DNA疫苗诱导的免疫。
Vaccines (Basel). 2014 Mar 25;2(2):196-215. doi: 10.3390/vaccines2020196.
4
A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.一种多头皮内电穿孔装置可实现对皮肤进行定制化且增加剂量的DNA疫苗递送。
Hum Vaccin Immunother. 2015;11(3):746-54. doi: 10.4161/21645515.2014.978223.
5
A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.一种多头皮内电穿孔装置能够实现向皮肤精准输送并增加剂量的DNA疫苗。
Hum Vaccin Immunother. 2014;10(10):3039-47. doi: 10.4161/hv.29671. Epub 2014 Nov 21.
6
Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.新型增强型靶向酪氨酸酶蛋白的抗黑色素瘤 DNA 疫苗抑制髓源抑制细胞并在同种异体预防性和治疗性小鼠模型中抑制肿瘤生长。
Cancer Gene Ther. 2014 Dec;21(12):507-17. doi: 10.1038/cgt.2014.56. Epub 2014 Nov 14.
7
Highly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity.高度优化的靶向人端粒酶逆转录酶的 DNA 疫苗刺激强烈的抗肿瘤免疫。
Cancer Immunol Res. 2013 Sep;1(3):179-189. doi: 10.1158/2326-6066.CIR-13-0001. Epub 2013 Jul 17.
8
Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.合成DNA疫苗引发的对H7N9流感病毒的保护性免疫
Vaccine. 2014 May 19;32(24):2833-42. doi: 10.1016/j.vaccine.2014.02.038. Epub 2014 Mar 12.
9
HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo.HIV-1 Env DNA 疫苗加 EP 递呈的蛋白加强免疫可在体内扩增 B 细胞和 T 细胞应答及中和表型。
PLoS One. 2013 Dec 31;8(12):e84234. doi: 10.1371/journal.pone.0084234. eCollection 2013.
10
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.HIV-1 DNA 疫苗联合白细胞介素 12 质粒的安全性和免疫原性及其肌肉内电穿孔递送的影响。
J Infect Dis. 2013 Sep 1;208(5):818-29. doi: 10.1093/infdis/jit236. Epub 2013 Jul 8.